LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 93

Search options

  1. Article ; Online: BAG3 expression and sarcomere localization in the human heart are linked to HSF-1 and are differentially affected by sex and disease.

    Martin, Thomas G / Tawfik, Sara / Moravec, Christine S / Pak, Toni R / Kirk, Jonathan A

    American journal of physiology. Heart and circulatory physiology

    2021  Volume 320, Issue 6, Page(s) H2339–H2350

    Abstract: Mutations to the sarcomere-localized cochaperone protein Bcl2-associated athanogene 3 (BAG3) are associated with dilated cardiomyopathy (DCM) and display greater penetrance in male patients. Decreased protein expression of BAG3 is also associated with ... ...

    Abstract Mutations to the sarcomere-localized cochaperone protein Bcl2-associated athanogene 3 (BAG3) are associated with dilated cardiomyopathy (DCM) and display greater penetrance in male patients. Decreased protein expression of BAG3 is also associated with nongenetic heart failure; however, the factors regulating cardiac BAG3 expression are unknown. Using left ventricular (LV) tissue from nonfailing and DCM human samples, we found that whole LV BAG3 expression was not significantly impacted by DCM or sex; however, myofilament localized BAG3 was significantly decreased in males with DCM. Females with DCM displayed no changes in BAG3 compared with nonfailing. This sex difference appears to be estrogen independent, as estrogen treatment in ovariectomized female rats had no impact on BAG3 expression. BAG3 gene expression in noncardiac cells is primarily regulated by the heat shock transcription factor-1 (HSF-1). We show whole LV HSF-1 expression and nuclear localized/active HSF-1 each displayed a striking positive correlation with whole LV BAG3 expression. We further found that HSF-1 localizes to the sarcomere
    MeSH term(s) Adaptor Proteins, Signal Transducing/metabolism ; Adult ; Aged ; Animals ; Apoptosis Regulatory Proteins/metabolism ; Cardiomyopathy, Dilated/metabolism ; Female ; Gene Expression ; Heart Ventricles/metabolism ; Heat Shock Transcription Factors/metabolism ; Humans ; Male ; Microscopy, Fluorescence ; Middle Aged ; Myocardium/metabolism ; Myocardium/pathology ; Myocytes, Cardiac/metabolism ; Myocytes, Cardiac/pathology ; Myofibrils/metabolism ; Ovariectomy ; Rats ; Sarcomeres/metabolism ; Sarcomeres/pathology ; Sex Factors
    Chemical Substances Adaptor Proteins, Signal Transducing ; Apoptosis Regulatory Proteins ; BAG3 protein, human ; BAG3 protein, rat ; HSF1 protein, human ; Heat Shock Transcription Factors ; Hsf1 protein, rat
    Language English
    Publishing date 2021-05-14
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 603838-4
    ISSN 1522-1539 ; 0363-6135
    ISSN (online) 1522-1539
    ISSN 0363-6135
    DOI 10.1152/ajpheart.00419.2020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Differential expression of members of SOX family of transcription factors in failing human hearts.

    Liu, Chia-Feng / Ni, Ying / Thachil, Varun / Morley, Michael / Moravec, Christine S / Tang, Wai Hong Wilson

    Translational research : the journal of laboratory and clinical medicine

    2021  Volume 242, Page(s) 66–78

    Abstract: The Sry-related high-mobility-group box (SOX) gene family, with 20 known transcription factors in humans, plays an essential role during development and disease processes. Several SOX proteins (SOX4, 11, and 9) are required for normal heart morphogenesis. ...

    Abstract The Sry-related high-mobility-group box (SOX) gene family, with 20 known transcription factors in humans, plays an essential role during development and disease processes. Several SOX proteins (SOX4, 11, and 9) are required for normal heart morphogenesis. SOX9 was shown to contribute to cardiac fibrosis. However, differential expression of other SOXs and their roles in the failing human myocardium have not been explored. Here, we used the whole-transcriptome sequencing (RNA-seq), gene co-expression, and meta-analysis to examine whether any SOX factors might play a role in the failing human myocardium. RNA-seq analysis was performed for cardiac tissue samples from heart failure (HF) patients due to dilated cardiomyopathy (DCM), or hypertrophic cardiomyopathy (HCM) and healthy donors (NF). The RNA levels of 20 SOX genes from RNA-seq data were extracted and compared to the 3 groups. Four SOX genes whose RNA levels were significantly upregulated in DCM or HCM compared to NF. However, only SOX4 and SOX8 proteins were markedly increased in the HF groups. A moderate to strong correlation was observed between the RNA level of SOX4/8 and fibrotic genes among each individual. Gene co-expression network analysis identified genes associated and respond similarly to perturbations with SOX4 in cardiac tissues. Using a meta-analysis combining epigenetics and genome-wide association data, we reported several genomic variants associated with HF phenotype linked to SOX4 or SOX8. In summary, our results implicate that SOX4 and SOX8 have a role in cardiomyopathy, leading to HF in humans. The molecular mechanism associated with them in HF warrants further investigation.
    MeSH term(s) Cardiomyopathy, Dilated/genetics ; Genome-Wide Association Study ; Humans ; RNA ; SOX Transcription Factors/genetics ; SOX Transcription Factors/metabolism ; SOXC Transcription Factors/genetics ; SOXE Transcription Factors/genetics ; Transcription Factors/genetics
    Chemical Substances SOX Transcription Factors ; SOX4 protein, human ; SOX8 protein, human ; SOXC Transcription Factors ; SOXE Transcription Factors ; Transcription Factors ; RNA (63231-63-0)
    Language English
    Publishing date 2021-10-22
    Publishing country United States
    Document type Journal Article ; Meta-Analysis ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2246684-8
    ISSN 1878-1810 ; 1532-6543 ; 1931-5244
    ISSN (online) 1878-1810 ; 1532-6543
    ISSN 1931-5244
    DOI 10.1016/j.trsl.2021.10.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The "How and Why" of Group Biofeedback for Chronic Disease Management.

    Fisher, Carolyn J / Moravec, Christine S / Khorshid, Lamees

    Applied psychophysiology and biofeedback

    2018  Volume 43, Issue 4, Page(s) 333–340

    Abstract: Biofeedback has been shown to have some level of efficacy for the treatment of a number of chronic medical conditions; however, individualized biofeedback treatment is not always feasible. While group- based interventions are growing in practice due to ... ...

    Abstract Biofeedback has been shown to have some level of efficacy for the treatment of a number of chronic medical conditions; however, individualized biofeedback treatment is not always feasible. While group- based interventions are growing in practice due to numerous advantages, the dearth of research examining the efficacy of Group Biofeedback (GBF) suggests that this treatment modality may not be commonly utilized. Thus, the current paper highlights some advantages and constructively addresses potential challenges of utilizing GBF. Obstacles specific to GBF include equipment for participants, need for support staffing, and billing. However, the potential benefits are numerous, and pertain to cost-effectiveness, improved patient access, and additive benefits specific to group-based treatment. We offer a six-session GBF protocol to be used to guide future clinical work in this area. We hope that through the ideas and protocol presented in this paper, biofeedback practitioners will be more inclined to implement GBF.
    MeSH term(s) Biofeedback, Psychology/methods ; Chronic Disease/therapy ; Clinical Protocols ; Humans ; Psychotherapy, Group/methods
    Language English
    Publishing date 2018-08-21
    Publishing country Germany
    Document type Journal Article ; Review
    ZDB-ID 1390949-6
    ISSN 1573-3270 ; 1090-0586
    ISSN (online) 1573-3270
    ISSN 1090-0586
    DOI 10.1007/s10484-018-9411-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Decreased FAM13B Expression Increases Atrial Fibrillation Susceptibility by Regulating Sodium Current and Calcium Handling.

    Tchou, Gregory / Ponce-Balbuena, Daniela / Liu, Nana / Gore-Panter, Shamone / Hsu, Jeffrey / Liu, Fang / Opoku, Emmanuel / Brubaker, Gregory / Schumacher, Sarah M / Moravec, Christine S / Barnard, John / Van Wagoner, David R / Chung, Mina K / Smith, Jonathan D

    JACC. Basic to translational science

    2023  Volume 8, Issue 10, Page(s) 1357–1378

    Abstract: A specific genetic variant associated with atrial fibrillation risk, rs17171731, was identified as a regulatory variant responsible for ... ...

    Abstract A specific genetic variant associated with atrial fibrillation risk, rs17171731, was identified as a regulatory variant responsible for controlling
    Language English
    Publishing date 2023-07-26
    Publishing country United States
    Document type Journal Article
    ISSN 2452-302X
    ISSN (online) 2452-302X
    DOI 10.1016/j.jacbts.2023.05.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Whole-Transcriptome Profiling of Human Heart Tissues Reveals the Potential Novel Players and Regulatory Networks in Different Cardiomyopathy Subtypes of Heart Failure.

    Liu, Chia-Feng / Ni, Ying / Moravec, Christine S / Morley, Michael / Ashley, Euan A / Cappola, Thomas P / Margulies, Kenneth B / Tang, W H Wilson

    Circulation. Genomic and precision medicine

    2021  Volume 14, Issue 1, Page(s) e003142

    MeSH term(s) Biomarkers/metabolism ; Cardiomyopathies/complications ; Cardiomyopathies/genetics ; Cardiomyopathies/pathology ; Down-Regulation ; Gene Expression Profiling/methods ; Gene Regulatory Networks/genetics ; Heart Failure/etiology ; Heart Failure/genetics ; Heart Failure/pathology ; Heart Ventricles/metabolism ; Humans ; Myocardium/metabolism ; Phenotype ; Receptor, Notch2/genetics ; Receptor, Notch2/metabolism ; Semaphorins/genetics ; Semaphorins/metabolism ; Signal Transduction/genetics ; Transcriptome ; Up-Regulation
    Chemical Substances Biomarkers ; NOTCH2 protein, human ; Receptor, Notch2 ; Sema4c protein, human ; Semaphorins
    Language English
    Publishing date 2021-02-01
    Publishing country United States
    Document type Letter ; Research Support, N.I.H., Extramural
    ISSN 2574-8300
    ISSN (online) 2574-8300
    DOI 10.1161/CIRCGEN.120.003142
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Biofeedback therapy in cardiovascular disease: rationale and research overview.

    Moravec, Christine S

    Cleveland Clinic journal of medicine

    2008  Volume 75 Suppl 2, Page(s) S35–8

    Abstract: Biofeedback has much therapeutic potential in cardiovascular diseases, since many of these diseases involve dysregulation of the autonomic nervous system. Studies have clearly demonstrated that patients can use biofeedback techniques to regulate the ... ...

    Abstract Biofeedback has much therapeutic potential in cardiovascular diseases, since many of these diseases involve dysregulation of the autonomic nervous system. Studies have clearly demonstrated that patients can use biofeedback techniques to regulate the input of the autonomic nervous system to the heart, but the clinical utility of these techniques has not been well explored in systematic trials. Much biofeedback research to date has focused on patients with hypertension, but outcomes have been inconclusive. Preliminary studies suggest that heart rate variability biofeedback may be useful in improving symptoms and quality of life in patients with cardiac disease, and early studies suggest a possible effect of biofeedback on remodeling of the failing heart. Both of these areas require further research, however. Biofeedback is increasingly used as an adjunct to stress management in cardiac rehabilitation programs, providing the impetus for a large-scale, systematic study of self-regulation in cardiac disease.
    MeSH term(s) Autonomic Nervous System/physiopathology ; Biofeedback, Psychology ; Cardiovascular Diseases/physiopathology ; Cardiovascular Diseases/therapy ; Heart Failure/prevention & control ; Heart Rate ; Humans ; Hypertension/prevention & control ; Stress, Psychological/complications ; Stress, Psychological/therapy
    Language English
    Publishing date 2008-06-03
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 639116-3
    ISSN 0891-1150
    ISSN 0891-1150
    DOI 10.3949/ccjm.75.suppl_2.s35
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Sex differences in myosin heavy chain isoforms of human failing and nonfailing atria.

    Reiser, Peter J / Moravec, Christine S

    American journal of physiology. Heart and circulatory physiology

    2014  Volume 307, Issue 3, Page(s) H265–72

    Abstract: Mammalian hearts express two myosin heavy chain (MHC) isoforms, which drive contractions with different kinetics and power-generating ability. The expression of the isoform that is associated with more rapid contraction kinetics and greater power output, ...

    Abstract Mammalian hearts express two myosin heavy chain (MHC) isoforms, which drive contractions with different kinetics and power-generating ability. The expression of the isoform that is associated with more rapid contraction kinetics and greater power output, MHC-α, is downregulated, with a concurrent increase in the relative amount of the slower isoform, MHC-β, during the progression to experimentally induced or disease-related heart failure. This change in protein expression has been well studied in right and left ventricles in heart failure models and in humans with failure. Relatively little quantitative data exists regarding MHC isoform expression shifts in human failing atria. We previously reported significant increases in the relative amount of MHC-β in the human failing left atrium. The results of that study suggested that there might be a sex-related difference in the level of MHC-β in the left atrium, but the number of female subjects was insufficient for statistical analysis. The objective of this study was to test whether there is, in fact, a sex-related difference in the level of MHC-β in the right and left atria of humans with cardiomyopathy. The results indicate that significant differences exist in atrial MHC isoform expression between men and women who are in failure. The results also revealed an unexpected twofold greater amount of MHC-β in the nonfailing left atrium of women, compared with men. The observed sex-related differences in MHC isoform expression could impact ventricular diastolic filling during normal daily activities, as well as during physiologically stressful events.
    MeSH term(s) Adolescent ; Adult ; Aged ; Cardiac Myosins/analysis ; Cardiomyopathies/metabolism ; Cardiomyopathies/physiopathology ; Case-Control Studies ; Female ; Heart Atria/chemistry ; Heart Atria/physiopathology ; Heart Failure/metabolism ; Heart Failure/physiopathology ; Humans ; Male ; Middle Aged ; Myosin Heavy Chains/analysis ; Sex Factors
    Chemical Substances MYH6 protein, human ; MYH7 protein, human ; Cardiac Myosins (EC 3.6.1.-) ; Myosin Heavy Chains (EC 3.6.4.1)
    Language English
    Publishing date 2014-05-30
    Publishing country United States
    Document type Comparative Study ; Journal Article
    ZDB-ID 603838-4
    ISSN 1522-1539 ; 0363-6135
    ISSN (online) 1522-1539
    ISSN 0363-6135
    DOI 10.1152/ajpheart.00810.2013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes.

    Wu, Xiaoqian / Liu, Huan / Brooks, Alan / Xu, Suowen / Luo, Jinque / Steiner, Rebbeca / Mickelsen, Deanne M / Moravec, Christine S / Jeffrey, Alexis D / Small, Eric M / Jin, Zheng Gen

    Circulation research

    2022  Volume 131, Issue 11, Page(s) 926–943

    Abstract: Background: Heart failure with preserved ejection fraction (HFpEF) is a growing health problem without effective therapies. Epidemiological studies indicate that diabetes is a strong risk factor for HFpEF, and about 45% of patients with HFpEF are ... ...

    Abstract Background: Heart failure with preserved ejection fraction (HFpEF) is a growing health problem without effective therapies. Epidemiological studies indicate that diabetes is a strong risk factor for HFpEF, and about 45% of patients with HFpEF are suffering from diabetes, yet the underlying mechanisms remain elusive.
    Methods: Using a combination of echocardiography, hemodynamics, RNA-sequencing, molecular biology, in vitro and in vivo approaches, we investigated the roles of SIRT6 (sirtuin 6) in regulation of endothelial fatty acid (FA) transport and HFpEF in diabetes.
    Results: We first observed that endothelial SIRT6 expression was markedly diminished in cardiac tissues from heart failure patients with diabetes. We then established an experimental mouse model of HFpEF in diabetes induced by a combination of the long-term high-fat diet feeding and a low-dose streptozocin challenge. We also generated a unique humanized SIRT6 transgenic mouse model, in which a single copy of human SIRT6 transgene was engineered at mouse
    Conclusions: The impairment of endothelial SIRT6 expression links diabetes to HFpEF through the alteration of FA transport across the endothelial barrier. Genetic and pharmacological strategies that restored endothelial SIRT6 function in mice with diabetes alleviated experimental HFpEF by limiting FA uptake and improving cardiac metabolism, thus warranting further clinical evaluation.
    MeSH term(s) Humans ; Mice ; Animals ; Stroke Volume/physiology ; Heart Failure/metabolism ; PPAR gamma ; Diabetes Mellitus, Experimental ; Disease Models, Animal ; Sirtuins/genetics ; Lipids
    Chemical Substances MDL-800 ; PPAR gamma ; Sirtuins (EC 3.5.1.-) ; Lipids ; SIRT6 protein, human (EC 3.5.1.-) ; Sirt6 protein, mouse (EC 2.4.2.31)
    Language English
    Publishing date 2022-10-24
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 80100-8
    ISSN 1524-4571 ; 0009-7330 ; 0931-6876
    ISSN (online) 1524-4571
    ISSN 0009-7330 ; 0931-6876
    DOI 10.1161/CIRCRESAHA.121.318988
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Circadian Pattern of Ion Channel Gene Expression in Failing Human Hearts.

    McTiernan, Charles F / Lemster, Bonnie H / Bedi, Kenneth C / Margulies, Kenneth B / Moravec, Christine S / Hsieh, Paishiun Nelson / Shusterman, Vladimir / Saba, Samir

    Circulation. Arrhythmia and electrophysiology

    2020  Volume 14, Issue 1, Page(s) e009254

    Abstract: Background: Ventricular tachyarrhythmias and sudden cardiac death show a circadian pattern of occurrence in patients with heart failure. In the rodent ventricle, a significant portion of genes, including some ion channels, shows a circadian pattern of ... ...

    Abstract Background: Ventricular tachyarrhythmias and sudden cardiac death show a circadian pattern of occurrence in patients with heart failure. In the rodent ventricle, a significant portion of genes, including some ion channels, shows a circadian pattern of expression. However, genes that define electrophysiological properties in failing human heart ventricles have not been examined for a circadian expression pattern.
    Methods: Ventricular tissue samples were collected from patients at the time of cardiac transplantation. Two sets of samples (n=37 and 46, one set with a greater arrhythmic history) were selected to generate pseudo-time series according to their collection time. A third set (n=27) of samples was acquired from the nonfailing ventricles of brain-dead donors. The expression of 5 known circadian clock genes and 19 additional ion channel genes plausibly important to electrophysiological properties were analyzed by real-time polymerase chain reaction and then analyzed for the percentage of expression variation attributed to a 24-hour circadian pattern.
    Results: The 5 known circadian clock gene transcripts showed a strong circadian expression pattern. Compared with rodent hearts, the human circadian clock gene transcripts showed a similar temporal order of acrophases but with a ≈7.6 hours phase shift. Five of the ion channel genes also showed strong circadian expression. Comparable studies of circadian clock gene expression in samples recovered from nonheart failure brain-dead donors showed acrophase shifts, or weak or complete loss of circadian rhythmicity, suggesting alterations in circadian gene expression.
    Conclusions: Ventricular tissue from failing human hearts display a circadian pattern of circadian clock gene expression but phase-shifted relative to rodent hearts. At least 5 ion channels show a circadian expression pattern in the ventricles of failing human hearts, which may underlie a circadian pattern of ventricular tachyarrhythmia/sudden cardiac death. Nonfailing hearts from brain-dead donors show marked differences in circadian clock gene expression patterns, suggesting fundamental deviations from circadian expression.
    MeSH term(s) Adult ; Circadian Rhythm ; Female ; Gene Expression ; Heart Failure/genetics ; Heart Failure/metabolism ; Heart Failure/physiopathology ; Humans ; Ion Channels/biosynthesis ; Ion Channels/genetics ; Male ; Middle Aged ; Myocardium/metabolism
    Chemical Substances Ion Channels
    Language English
    Publishing date 2020-12-10
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2426129-4
    ISSN 1941-3084 ; 1941-3149
    ISSN (online) 1941-3084
    ISSN 1941-3149
    DOI 10.1161/CIRCEP.120.009254
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Epistasis regulates genetic control of cardiac hypertrophy.

    Wang, Qianru / Tang, Tiffany M / Youlton, Nathan / Weldy, Chad S / Kenney, Ana M / Ronen, Omer / Hughes, J Weston / Chin, Elizabeth T / Sutton, Shirley C / Agarwal, Abhineet / Li, Xiao / Behr, Merle / Kumbier, Karl / Moravec, Christine S / Tang, W H Wilson / Margulies, Kenneth B / Cappola, Thomas P / Butte, Atul J / Arnaout, Rima /
    Brown, James B / Priest, James R / Parikh, Victoria N / Yu, Bin / Ashley, Euan A

    medRxiv : the preprint server for health sciences

    2023  

    Abstract: The combinatorial effect of genetic variants is often assumed to be additive. Although genetic variation can clearly interact non-additively, methods to uncover epistatic relationships remain in their infancy. We develop low-signal signed iterative ... ...

    Abstract The combinatorial effect of genetic variants is often assumed to be additive. Although genetic variation can clearly interact non-additively, methods to uncover epistatic relationships remain in their infancy. We develop low-signal signed iterative random forests to elucidate the complex genetic architecture of cardiac hypertrophy. We derive deep learning-based estimates of left ventricular mass from the cardiac MRI scans of 29,661 individuals enrolled in the UK Biobank. We report epistatic genetic variation including variants close to
    Language English
    Publishing date 2023-11-08
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.11.06.23297858
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top